Differences in stem cell marker and osteopontin expression in primary and recurrent glioblastoma.

Bülent PolatGisela WohllebenRebekka KosmalaDominik LisowskiFrederick MantelVictor LewitzkiMario LöhrRobert BlumPetra HerudMichael FlentjeCamelia-Maria Monoranu

Published in: Cancer cell international (2022)

Most of the evaluated markers showed an increased expression in their recurrent tumor. CD133 and Nestin were associated with survival and are candidate markers for further clinical investigation.

Keyphrases

nk cells
poor prognosis
stem cells
long non coding rna
mesenchymal stem cells
bone marrow